Emerging Hyperprolactinemic Galactorrhea in Obsessive Compulsive Disorder with a Stable Dose of Fluoxetine.
10.9758/cpn.2015.13.3.316
- Author:
Seshadri Sekhar CHATTERJEE
1
;
Sayantanava MITRA
;
Nitu MALLIK
Author Information
1. Department of Psychiatry, Medical College, Kolkata, India.
- Publication Type:Case Report
- Keywords:
Fluoxetine;
Galactorrhea;
Hyperprolactinemia;
Selective serotonin reuptake inhibitors
- MeSH:
Female;
Fluoxetine*;
Galactorrhea*;
Hyperprolactinemia;
Individuality;
Obsessive-Compulsive Disorder*;
Pregnancy;
Prolactin;
Secretory Pathway;
Serotonin;
Serotonin Uptake Inhibitors;
Sertraline
- From:Clinical Psychopharmacology and Neuroscience
2015;13(3):316-318
- CountryRepublic of Korea
- Language:English
-
Abstract:
While fluoxetine (FXT) is a frequently prescribed selective serotonin reuptake inhibitor (SSRI), with few major side-effects; altered serotonergic transmissions in hypothalamic pathways might lead to a distressing, and often embarrassing, manifestation of galactorrhea by altering prolactin release in those on FXT. We report here a case of FXT-induced hyperprolactinemic galactorrhea developing late into treatment on a stable regimen, who responded well to subsequent replacement with sertraline. Based on present finding, we suggest that while SSRIs may share similar mechanisms of action, there exist individual differences in their effects on prolactin secretion pathways.
